Evaluation of the Efficacy of Ambu® aScope for Intubation in Cancer Tongue
Randomized- Single Blind Trial of Ambu Ascope and Fiberoptic in Severely Difficult Air Way Patient Having Posterior Third Fixed Tongue Cancer
1 other identifier
interventional
100
1 country
1
Brief Summary
This study compares the ascope with standard fiberscope using the nasal route of intubation in patient having sever difficult airway (having posterior one third cancer tongue with fixed mobility)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedFirst Submitted
Initial submission to the registry
June 22, 2019
CompletedFirst Posted
Study publicly available on registry
June 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 19, 2020
CompletedOctober 10, 2022
October 1, 2022
1.8 years
June 22, 2019
October 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
time of successful intubation
measuring time in seconds for reaching carina and time for successful intubation .
5 minutes
Secondary Outcomes (4)
quality of vision
5 minutes
incidence of complications
15 minutes
easiness of intubation
5 minutes
number of intubation trials
30 minutes
Study Arms (2)
ambu scope
EXPERIMENTALintubation of cancer tongue patients with ambu scope device
fiberoptic
ACTIVE COMPARATORintubation of cancer tongue patients with fiberoptic device
Interventions
nasal route intubation by the device in fixed cancer tongue patients
nasal route intubation by the device in fixed cancer tongue patients
Eligibility Criteria
You may qualify if:
- Adult patients of ASA physical status I and II who will be scheduled for posterior third fixed cancer tongue with severe difficult airway requiring naso-tracheal intubation
- aged 18-70 years
You may not qualify if:
- ASA 2 or 4
- pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- mahmoud salem solimanlead
- Cairo Universitycollaborator
Study Sites (1)
Kasr Alini Univeristy Hospital
Cairo, Giza Governorate, 11451, Egypt
Related Publications (3)
Reeves DS, Brown NM. Mycobacterial contamination of fibreoptic bronchoscopes. J Hosp Infect. 1995 Jun;30 Suppl:531-6. doi: 10.1016/0195-6701(95)90059-4.
PMID: 7560994BACKGROUNDHan DW, Shim YH, Shin CS, Lee YW, Lee JS, Ahn SW. Estimation of the length of the nares-vocal cord. Anesth Analg. 2005 May;100(5):1533-1535. doi: 10.1213/01.ANE.0000149900.68354.33.
PMID: 15845720BACKGROUNDMarfin AG, Iqbal R, Mihm F, Popat MT, Scott SH, Pandit JJ. Determination of the site of tracheal tube impingement during nasotracheal fibreoptic intubation. Anaesthesia. 2006 Jul;61(7):646-50. doi: 10.1111/j.1365-2044.2006.04652.x.
PMID: 16792609BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Ekramy M Abdelghafar, MD
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- patient will be under general anesthesia
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of intensive care unit at new kaser al ainy teaching hospital , lecterur of anaesthesia and intensive care cairo universty .
Study Record Dates
First Submitted
June 22, 2019
First Posted
June 26, 2019
Study Start
August 1, 2018
Primary Completion
May 5, 2020
Study Completion
May 19, 2020
Last Updated
October 10, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- 3 months
- Access Criteria
- open
De-identified participant data for primary and secondary outcome measures will be made available